A new drug for pancreatic cancer, one of the deadliest cancers, saw patients live almost double the time compared to those ...
The National on MSN
Obesity doubles cancer risk, new research shows
Unhealthy weight in older age leaves men and women vulnerable to early death ...
The warning comes after an analysis of over 600,000 men and women who were weighed repeatedly over four decades found there ...
A personalized DNA vaccine for glioblastoma, an aggressive and incurable brain cancer, appears safe and shows early signs of ...
Researchers have uncovered an unexpected weakness in pancreatic cancer involving damaged mitochondria and a powerful ...
New data from the American Cancer Society shows that the five-year survival rate for pancreatic cancer patients is just 13%.
Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C. She started covering consumer health in the midst of the pandemic, reporting on everything from ...
It is poised to revolutionize cancer treatment. An experimental drug that targets pancreatic cancer is being fast tracked for ...
Scientists long ago identified their target: a smooth-surfaced protein inside cells, called KRAS, that is altered in certain ...
Pancreatic cancer is notoriously lethal. But new treatments mean that may be changing, and people with the disease now have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results